The monoclonal antibody SM5-1 recognizes a fibronectin variant which is widely expressed in melanoma

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Trefzer, Uwe ^a   Chen, Yingwen ^a   Herberth, Gunda ^b   Hofmann, Maja Ann ^a   Kiecker, Felix ^a   Guo, Yajun ^c   Sterry, Wolfram ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FIBRONECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SM5 1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BACTERIOPHAGE LAMBDA; CARCINOGENESIS; CELL ADHESION; CELL SPREADING; CLONE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DNA LIBRARY; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN VARIANT; SEQUENCE ANALYSIS;

EID: 32044469141     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-8     Document Type: Article

References (56)

1. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS: Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 1994, 54:1561-1565.
2. Trefzer U, Rietz N, Chen Y, Audring H, Herberth G, Siegel P, Reinke S, Koniger P, Wu S, Ma J, Liu Y, Wang H, Sterry W, Guo Y: SM5-I: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions. Arch Dermatol Res 2000, 292:583-589.
3. Reinke S, Koeniger P, Herberth G, Audring H, Wang H, Ma J, Guo Y, Sterry W, Trefzer U: Differential expression of MART-I, Tyrosinase and SMIS-I in primary and metastatic melanoma. Am J Dermatopathol 2005, 27:402-407.
4. Dear TN, McDonald DA, Kefford RF: Transcriptional down-regulation of a rat gene, WDNM2, in metastatic DMBA-8 cells. Cancer Res 1989, 49:5323-5328.
5. Kalebic T, Williams JE, Talmadge JE, Kao-Shan CS, Kravitz B, Locklear K, Slegal GP, Liotta LA, Sobel ME, Steeg PS: A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K 1735 melanoma cell lines based on in vitro and in vivo invasive capacity. Clin Exp Metastasis 1988, 6:301-318.
6. Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y, Kandpal RP: Tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DUI 45. Cancer Detect Prev 1999, 23:325-332.
7. Short JM, Fernandez JM, Sorge JA, Huse WD: Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids Res 1988, 16:7583-7600.
8. Hynes RO: Fibronectins: a family of complex and versatile adhesive glycoproteins derived from a single gene. Harvey Lect 1985, 81:133-152.
9. Pankov R, Cukierman E, Katz BZ, Matsumoto K, Lin DC, Lin S, Hahn C, Yamada KM: Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha(5)beta(1) integrins promotes early fibronectin fibrillogenesis. J Cell Biol 2000, 148:1075-1090.
10. Johnson KJ, Sage H, Briscoe G, Erickson HP: The compact conformation of fibronectin is determined by intramolecular ionic interactions. J Biol Chem 1999, 274:15473-15479.
11. Paul JI, Schwarzbauer JE, Tamkun JW, Hynes RO: Cell-type-specific fibronectin subunits generated by alternative splicing. J Biol Chem 1986, 261:12258-12265.
12. Engel J, Odermatt E, Engel A, Madri JA, Furthmayr H, Rohde H, Timpl R: Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol 1981, 150:97-120.
13. Garcia-Pardo A, Rostagno A, Frangione B: Primary structure of human plasma fibronectin. Characterization of a 38 kDa domain containing the C-terminal heparin-binding site (Hep III site) and a region of molecular heterogeneity. Biochem J 1987, 241:923-928.
14. Patel RS, Odermatt E, Schwarzbauer JE, Hynes RO: Organization of the fibronectin gene provides evidence for exon shuffling during evolution. EMBO J 1987, 6:2565-2572.
15. Kornblihtt AR, Vibe-Pedersen K, Baralle FE: Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J 1984, 3:221-226.
16. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle FE: Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 1985, 4:1755-1759.
17. Norton PA, Hynes RO: Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells. Mol Cell Biol 1987, 7:4297-4307.
18. Schwarzbauer JE, Patel RS, Fonda D, Hynes RO: Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J 1987, 6:2573-2580.
19. Sekiguchi K, Klos AM, Hirohashi S, Hakomori S: Human tissue fibronectin: expression of different isotypes in the adult and fetal tissues. Biochem Biophys Res Commun 1986, 141:1012-1017.
20. Borsi L, Carnemolla B, Castellani P, Rosellini C, Vecchio D, Allemanni G, Chang SE, Taylor-Papadimitriou J, Pande H, Zardi L Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol 1987, 104:595-600.
21. Wierzbicka-Patynowski I, Schwarzbauer JE: The ins and outs of fibronectin matrix assembly. J Cell Sci 2003, 116:3269-3276.
22. Ugarova TP, Ljubimov AV, Deng L, Plow EF: Proteolysis regulates exposure of the IIICS-I adhesive sequence in plasma fibronectin. Biochemistry 1996, %20;35:10913-10921.
23. Sechler JL, Cumiskey AM, Gazzola DM, Schwarzbauer JE: A novel RGD-independent fibronectin assembly pathway initiated by alpha4betal Integrin binding to the alternatively spliced V region. J Cell Sci 2000, 113:1491-1498.
24. Ohashi T, Kiehart DP, Erickson HP: Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc Natl Acad Sci U S A 1999, 96:2153-2158.
25. Hormann H: Fibronectin - mediator between cells and connective tissue. Klin Wochenschr 1982, 60:1265-1277.
26. Ruoslahti E, Pierschbacher MD: New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497.
27. Qian F, Zhang ZC, Wu XF, Li YP, Xu Q: Interaction between integrin alpha(5) and fibronectin is required for metastasis of B 16F 10 melanoma cells. Biochem Biophys Res Commun 2005, 333:1269-1275.
28. Cukierman E, Pankov R, Stevens DR, Yamada KM: Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
29. Manabe R, Oh-e N, Sekiguchi K: Alternatively spliced EDA segment regulates fibronectin-dependent cell cycle progression and mitogenic signal transduction. J Biol Chem 1999, 274:5919-5924.
30. Ingham KC, Brew SA, Huff S, Litvinovich SV: Cryptic self-association sites in type III modules of fibronectin. J Biol Chem 1997, 272:1718-1724.
31. Morla A, Zhang Z, Ruoslahti E: Superfibronectin is a functionally distinct form of fibronectin. Nature 1994, 367:193-196.
32. Sechler JL, SchwarzbauerJE: Coordinated regulation of fibronectin fibril assembly and actin stress fiber formation. Cell Adhes Commun 1997, 4:413-424.
33. Sechler JL, Takada Y, Schwarzbauer JE: Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J Cell Biol 1996, 134:573-583.
34. Ugarova TP, Zamarron C, Veklich Y, Bowditch RD, Ginsberg MH, Weisel JW, Plow EF: Conformational transitions in the cell binding domain of fibronectin. Biochemistry 1995, 34:4457-4466.
35. Natali PG, Nicotra MR, Di Filippo F, Bigotti A: Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer 1995, 71:1243-1247.
36. Xia P, Culp LA: Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA): complementarity to plasma fibronectin functions. Exp Cell Res 1995, 217:517-527.
37. Guan JL, Trevithick JE, Hynes RO: Retroviral expression of alternatively spliced forms of rat fibronectin. J Cell Biol 1990, 110:833-847.
38. Hynes RO, George EL, Georges EN, Guan JL, Rayburn H, Yang JT: Toward a genetic analysis of cell-matrix adhesion. Cold Spring Harb Symp Quant Biol 1992, 57:249-258.
39. Ruoslahti E: Fibronectin in cell adhesion and invasion. Cancer Metastasis Rev 1984, 3:43-51.
40. Barone MV, Henchcliffe C, Baralle FE, Paolella G: Cell type specific trans-acting factors are involved in alternative splicing of human fibronectin pre-mRNA. EMBO J 1989, 8:1079-1085.
41. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, Natali PG: A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 1989, 108:1139-1148.
42. Ffrench-Constant C, Hynes RO: Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 1989, 106:375-388.
43. Glukhova MA, Frid MG, Shekhonin BV, Balabanov YV, Koteliansky VE: Expression of fibronectin variants in vascular and visceral smooth muscle cells in development. Dev Biol 1990, 141:193-202.
44. Laitinen L, Vartio T, Virtanen I: Cellular fibronectins are differentially expressed in human fetal and adult kidney. Lab Invest 1991, 64:492-498.
45. Pagani F, Zagato L, Vergani C, Casari G, Sidoli A, Baralle FE: Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 1991, 113:1223-1229.
46. Humphries MJ, Olden K, Yamada KM: A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986, 233:467-470.
47. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309:30-33.
48. Pierschbacher MD, Dedhar S, Ruoslahti E, Argraves S, Suzuki S: An adhesion variant of the MG-63 osteosarcoma cell line displays an osteoblast-like phenotype. Ciba Found Symp 1988, 136:131-141.
49. Humphries MJ, Yasuda Y, Olden K, Yamada KM: The cell interaction sites of fibronectin in tumour metastasis. Ciba Found Symp 1988, 141:75-93.
50. Saiki I, Murata J, Iida J, Sakurai T, Nishi N, Matsuno K, Azuma I: Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences. Br J Cancer 1989, 60:722-728.
51. Humphries MJ, Komoriya A, Akiyama SK, Olden K, Yamada KM: Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem 1987, 262:6886-6892.
52. McKeown-Longo PJ, Mosher DF: Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol 1983, 97:466-472.
53. Roman J, LaChance RM, Broekelmann TJ, Kennedy CJ, Wayner EA, Carter WG, McDonald JA: The fibronectin receptor is organized by extracellular matrix fibronectin: implications for oncogenic transformation and for cell recognition of fibronectin matrices. J Cell Biol 1989, 108:2529-2543.
54. Hayman EG, Engvall E, Ruoslahti E: Concomitant loss of cell surface fibronectin and laminin from transformed rat kidney cells. J Cell Biol 1981, 88:352-357.
55. Ebbinghaus C, Scheuermann J, Neri D, Elia G: Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis. Curr Pharm Des 2004, 10:1537-1549.
56. Menrad A, Menssen HD: ED-B fibronectin as a target for antibody-based cancer treatments. Expert Opin Ther Targets 2005, 9:491-500.